Sponsor:
Elizabeth C. Verna
Code:
NCT06455280
Conditions
Autoimmune Liver Disease
Liver Transplant Disorder
Autoimmune Hepatitis
Primary Sclerosing Cholangitis
End Stage Liver DIsease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Siplizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Elizabeth C. Verna on 2024-11-12.